By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Scancell, Ltd. 

P.O. Box 6457

Nottingham    NG5 1QA  United Kingdom
Phone: 44-0-115-962-8033 Fax: +44-0-115-962-8033



Company News
Scancell: Translating Innovative Science Into Ground-Breaking New Products 10/20/2015 12:32:15 PM
Scancell Strengthens Operational And Clinical Development Expertise 10/14/2015 10:14:28 AM
Scancell Release: Six Scientific Presentations At The Progress In Vaccination Against Cancer Conference Highlight Potential Of Immunobody And Moditope Platform Technologies 10/6/2015 9:50:02 AM
Scancell Final Results For The Year Ended 30 April 2015 9/18/2015 9:01:15 AM
Scancell’s Immunobody Platform Being Presented At The Cancer Vaccines Conference, London 9/16/2015 9:21:24 AM
Scancell And Immunid Announce Collaboration To Predict SCIB1 Responders Using Immuntracker 7/30/2015 9:22:27 AM
Scancell Patient Recruitment Completed For SCIB1 Phase 1/2 Clinical Trial 7/9/2015 8:22:19 AM
ASCO15: Scancell Provides Positive Update On SCIB1 Data In Resected Melanoma Patients 6/2/2015 9:31:04 AM
Scancell To Provide Update On SCIB1 Data In Resected Melanoma Patients At 2015 ASCO Annual Meeting 5/18/2015 12:41:09 PM
Scancell To Provide Positive SCIB1 Phase 1/2 Clinical Trial Update During Corporate Presentations 12-15 January, San Francisco 1/12/2015 11:21:26 AM